Clinical Trial Update: A Study to Learn How Effective is PCV20 to Help Stop Adults Who Have a Higher Chance of Getting Pneumonia

View source ↗

Summary

Pfizer's PCV20 clinical trial aims to evaluate the vaccine's effectiveness in adults at higher risk of pneumonia. The study status is ACTIVE_NOT_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumonia

Drugs mentioned

• PCV20 (20-valent pneumococcal conjugate vaccine)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia | Status: ACTIVE_NOT_RECRUITING